BRIEFING. Nonharmonized attributes: Identification, Heavy metals, Characters, Labeling, Bacterial endotoxins, Sterility, Storage.

Similar documents
» Monohydrate Citric Acid contains one molecule of water of hydration. It contains not less than 99.5 percent and not more than 100.

MONOGRAPHS (USP) Saccharin Sodium

MONOGRAPHS (NF) Pharmacopeial Forum 616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005]

Change to read: BRIEFING

BRIEFING Assay + + +

BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Identification B Identification C + + +

BRIEFING. 1. Definition Changed to include only Wheat Starch, as to conform to the individual monograph for Wheat Starch.

» Croscarmellose Sodium is a cross linked polymer of carboxymethylcellulose sodium.

BRIEFING. Nonharmonized attributes: Characters, Microbial Enumeration Tests, and Tests for Specified Microorganisms, and Packing and Storage (USP)

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB

Petrolatum. Stage 4, Revision 1. Petrolatum is a purified semi solid mixture of hydrocarbons obtained from petroleum.

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB1886.

Draft proposal for The International Pharmacopoeia

6.02 Uniformity of Dosage Units

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

INTERIM REVISION ANNOUNCEMENT

HYDROXYPROPYLCELLULOSE, LOW SUBSTITUTED Stage 4, Revision 1 CP: USP BRIEFING NOTE

contents of the monograph in effect today. Please refer to the current edition of the USP NF for official text.

CELLULOSE, MICROCRYSTALLINE. Cellulosum microcristallinum. Cellulose, microcrystalline EUROPEAN PHARMACOPOEIA 7.0

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

ARTENIMOLUM ARTENIMOL. Adopted revised text for addition to The International Pharmacopoeia

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

GB Translated English of Chinese Standard: GB NATIONAL STANDARD

Hydroxypropyl Starch (Tentative)

Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA

Purity Tests for Modified Starches

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

E17 ETHYLCELLULOSE. Revision 3 Stage 4

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

Should you have any questions, please contact Heather Joyce, Ph.D., Senior Scientific Liaison ( or

Pectins. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016

Official Journal of the European Union REGULATIONS

Feedstuffs Analysis G-22-1 PROTEIN

Final text for addition to The International Pharmacopoeia (June 2010)

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN THE FOURTH EDITION OF The International Pharmacopoeia

Diltiazem Hydrochloride Extended-Release Capsules. Type of Posting Posting Date Official Date

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras)

COMMENTARY TO USP31 - NF26

Quetiapine Tablets. Expert Committee Monographs Chemical Medicines 4 Reason for Revision Compliance

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

Amendment of Standards for Specification, Scope, Application and Limitation of Food Additives

1 out of 8. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 86th Meeting 2018 ERYTHROSINE

European Pharmacopoeia solutions

INTERNATIONAL ŒNOLOGICAL CODEX. PROTEIN PLANT ORIGIN FROM WHEAT, PEAS and POTATOES (OENO 28/2004, ) OIV-OENO OIV-OENO

Corn Starch Analysis B-47-1 PHOSPHORUS

Compliance. Should you have any questions, please contact Behnaz Almasi, Associate Scientific Liaison ( or

Revisions to USP 31 NF 26, Second Supplement

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS

THERMALLY OXIDIZED SOYA BEAN OIL

Lutein Esters from Tagetes Erecta

Nitrate and Nitrite Key Words: 1. Introduction 1.1. Nature, Mechanism of Action, and Biological Effects (Fig. 1)

E55A GELATIN, GELLING GRADE Gelatina

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

Heparin Sodium ヘパリンナトリウム

INTERNATIONAL ŒNOLOGICAL CODEX. BENTONITES Bentonita N SIN: 558 (Oeno 11/2003 modified Oeno )

PHCH 402: Analytical Quality Control Different methods of analysis of some groups of drugs in common use in Nigeria (8 hrs)

CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012)

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB5009.

21 Virginiamycin OH O. For chickens (except for broilers) broilers. Added amount 5~15 5~15 10~20 10~20

Student Practical Guide (1) Milk of Magnesia

Revision Bulletin 23 Feb Mar 2018 Chemical Medicines Monographs 3 Compliance

Tramadol Hydrochloride Extended-Release Tablets. Expert Committee Chemical Medicines Monographs 2 Reason for Revision Compliance

DRAFT EAST AFRICAN STANDARD

4. Determination of fat content (AOAC, 2000) Reagents

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

TENOFOVIRI DISOPROXILIS FUMARAS TENOFOVIR DISOPROXIL FUMARATE

SOUTH AFRICAN NATIONAL STANDARD

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

B - Barium chloride (0.1 mol/l) VS... Butylated hydroxytoluene R

Should you have any questions, please contact Heather Joyce, Ph.D., Senior Scientific Liaison ( or

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

Revisions to USP 30 NF 25, Second Supplement

Draft Indian Standard SODIUM HYDROXIDE, FOOD GRADE SPECIFICATION

CHAPTER 3: MATERIALS AND METHODS

Chemical Pharmaceutical Quality Control. Prof.Dr.Joumaa Al- Zehouri Damascus university Faculty of Pharmacy

905 UNIFORMITY OF DOSAGE UNITS

By Authority Of THE UNITED STATES OF AMERICA Legally Binding Document

Compliance. Minor editorial changes have been made to update the monograph to the current USP style.

National Standard of the People s Republic of China. National food safety standard. Determination of pantothenic acid in foods for infants and

Enzymatic Assay of POLYGALACTURONASE (EC )

Hardness, Total, Sequential

PROPOSAL FOR REVISION OF MONOGRAPH IN THE FOURTH EDITION OF The International Pharmacopoeia MEFLOQUINE HYDROCHLORIDE (JANUARY 2012) DRAFT FOR COMMENT

Hydroponics TEST KIT MODEL AM-41 CODE 5406

Yeast, Autolyzed. a dry place.

INTERNATIONAL ŒNOLOGICAL CODEX. DETERMINATION OF BETA-GLUCANASE (ß 1-3, ß 1-6) ACTIVITY IN ENZYME PREPARATIONS (Oeno 340/2010, Oeno )

Method (6 to 1000 µg/l Chlorine as Cl 2 ) Digital Titrator

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010)

B. 1% (w/v) Salicin Substrate Solution (Salicin) (Prepare 50 ml in Reagent A using Salicin, Sigma Prod. No. S-0625.)

II-C- CHECKING RAW MATERIALS

ASHXX ASH (Residue on Ignition)

EXPERIMENT 4 DETERMINATION OF REDUCING SUGARS, TOTAL REDUCING SUGARS, SUCROSE AND STARCH

Transcription:

BRIEFING Citric Acid, Anhydrous, page 872 of PF 28(3) [May June 2002]. The European Pharmacopoeia is the coordinating pharmacopeia for the international harmonization of the compendial standards for the Citric Acid, Anhydrous monograph, as part of the process of international harmonization of monographs and general analytical methods of the European, Japanese, and United States pharmacopeias. The following monograph, which represents the ADOPTION STAGE 6 document, is based on the corresponding monograph for Citric Acid, Anhydrous that was prepared by the European Pharmacopoeia. The European Pharmacopoeia draft was based in part on comments from the Japanese Pharmacopoeia and the United States Pharmacopeia in response to the Provisional Harmonized Text Stage 5A and 5B drafts prepared by the European Pharmacopoeia. The current USP monograph for Citric Acid will be replaced with two separate monographs for Anhydrous Citric Acid and Citric Acid Monohydrate. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition + + + Appearance of solution + + + Readily carbonizable substances + + + Oxalic acid + + + Sulfates + + + Aluminium + + Water + + + Sulphated ash + + + Assay + + + Legend: + will adopt and implement; will not stipulate. Nonharmonized attributes: Identification, Heavy metals, Characters, Labeling, Bacterial endotoxins, Sterility, Storage. Reagents and reference materials: Each pharmacopeia will adapt the text to take account of local reference substances and spectra and reagent specifications. Differences between the European Pharmacopoeia Adoption Stage 6 document and the current USP monograph include the following: 1. Definition Changed to include only Anhydrous Citric Acid in order to conform to the individual monograph for Anhydrous Citric Acid. 2. Packaging No change. 3. Labeling The indication of anhydrous or hydrous is deleted in order to conform to the individual monograph for Anhydrous Citric Acid. A requirement that the label indicates where it is intended for use in dialysis solutions is added. Considerations for bacterial endotoxins and sterility are added. http://www.usppf.com/pf/pub/index.html 1/6

4. USP Reference standards A USP Citric Acid Reference Standard that is used in the Identification test is added. 5. Clarity of solution This test is added in order to conform with EP standards. 6. Color of solution This test is added in order to conform with EP standards. 7. Identification The test for citrate is deleted, and a more definitive infrared absorption test is added. 8. Bacterial endotoxins Statements are added that refer to the limits under the appropriate dosage form monograph. Specific requirements have been omitted. 9. Sterility Statements are added that refer to the limits under the appropriate dosage form monograph. 10. Water The standard for this test is increased from 0.5% to 1.0% in order to conform with EP standards. 11. Residue on ignition The standard for this test is increased from 0.05% to 0.1% in order to conform with JP standards. 12. Readily carbonizable substances No change. 13. Sulfate The test procedure is changed to a quantitative test in order to conform to EP standards. 14. Arsenic This test is deleted because the Heavy metals test sufficiently accounts for arsenic. 15. Heavy metals No change. 16. Limit of oxalic acid The test procedure is changed to a quantitative test in order to conform to EP standards. 17. Limit of aluminum This test is added in order to conform with EP standards concerning usage in dialysis. This requirement is similar to the Limit of aluminum in the USP Calcium Acetate monograph. 18. Organic volatile impurities No change. 19. Assay The sample size is decreased from 3 g in 40 ml of water to 0.55 g in 50 ml of water. The amount of Anhydrous Citric Acid that is equivalent to 1 ml of 1 N sodium hydroxide is changed to specify a more accurate quantity (i.e., from 64.04 mg to 64.03 mg). (EMC: J. Lane ) RTS 40769 2 Add the following: Citric Acid, Anhydrous Anhydrous Citric Acid C 6 H 8 O 7 192.13 1,2,3 Propanetricarboxylic acid, 2 hydroxy. Citric acid [77 92 9]. http://www.usppf.com/pf/pub/index.html 2/6

» Anhydrous Citric Acid contains not less than 99.5 percent and not more than 100.5 percent of C 6 H 8 O 7, calculated on the anhydrous basis. Packaging and storage Preserve in tight containers. Labeling Where it is intended for use in dialysis solutions, it is so labeled. Where Anhydrous Citric Acid must be subjected to further processing during the preparation of injectable dosage forms to ensure acceptable levels of bacterial endotoxins, it is so labeled. Where Anhydrous Citric Acid is sterile, it is so labeled. USP Reference standards 11 USP Citric Acid RS. Clarity of solution [ NOTE The Test solution is to be compared to Reference suspension A in diffused daylight 5 minutes after preparation of Reference suspension A. ] Hydrazine sulfate solution Transfer 1.0 g of hydrazine sulfate to a 100 ml volumetric flask, dissolve in and dilute with water to volume, and mix. Allow to stand for 4 to 6 hours before use. Hexamethylenetetramine solution Methenamine solution Transfer 2.5 g of Hexamethylenetetramine Methenamine to a 100 ml glassstoppered flask, add 25.0 ml of water, insert the glass stopper, and mix to dissolve. Primary opalescent suspension [ NOTE This suspension is stable for 2 months, provided it is stored in a glass container free from surface defects. The suspension must not adhere to the glass and must be well mixed before use. ] Transfer 25.0 ml of Hydrazine sulfate solution to the Hexamethylenetetramine solution Methenamine solution in the 100 ml glass stoppered flask. Mix, and allow to stand for 24 hours. Opalescence standard [ NOTE This suspension should not be used beyond 24 hours after preparation. ] Transfer 15.0 ml of the Primary opalescent suspension to a 1000 ml volumetric flask, dilute with water to volume, and mix. Reference suspensions Transfer 5.0 ml of the Opalescence standard to a 100 ml volumetric flask, dilute with water to volume, and mix to obtain Reference suspension A. Transfer 10.0 ml of the Opalescence standard to a second 100 ml volumetric flask, dilute with water to volume, and mix to obtain Reference suspension B. Test solution Dissolve 2.0 g of Anhydrous Citric Acid in about 5 ml of water, dilute with water to 10 ml, and mix. Procedure Transfer a sufficient portion of the Test solution to a test tube of colorless, transparent, neutral glass with a flat base and an internal diameter of 15 to 25 mm to obtain a depth of 40 mm. Similarly transfer portions of Reference suspension A, Reference suspension B, and water to separate matching test tubes. Compare the Test solution, Reference suspension A, Reference suspension B, and water in diffused daylight, viewing vertically against a black background (see Visual Comparison under Spectrophotometry and Light Scattering 851 ). [ NOTE The diffusion of light must be such that Reference suspension A can readily be distinguished from water, and that Reference suspension B can readily be distinguished from Reference suspension A. ] The Test solution shows the same clarity as that of water. Color of solution Standard stock solutions Prepare three solutions, A, B, and C, containing, respectively, the following parts of ferric chloride CS, cobaltous chloride CS, cupric sulfate CS, and dilute hydrochloric acid (10 g per L): http://www.usppf.com/pf/pub/index.html 3/6

A 2.4:0.6:0:7.0. B 2.4:1.0:0.4:6.2. C 9.6:0.2:0.2:0. Standard solutions [ NOTE Prepare the Standard solutions immediately before use. ] Transfer 2.5 ml of Standard stock solution A to a 100 ml volumetric flask, dilute with dilute hydrochloric acid (10 g per L) to volume, and mix to obtain Standard solution A. Transfer 2.5 ml of Standard stock solution B to a 100 ml volumetric flask, dilute with dilute hydrochloric acid (10 g per L) to volume, and mix to obtain Standard solution B. Transfer 0.75 ml of Standard stock solution C to a 100 ml volumetric flask, dilute with dilute hydrochloric acid (10 g per L) to volume, and mix to obtain Standard solution C. Test solution Use the Test solution prepared as directed in the test for Clarity of solution. Procedure Transfer a sufficient portion of the Test solution to a test tube of colorless, transparent, neutral glass with a flat base and an internal diameter of 15 to 25 mm to obtain a depth of 40 mm. Similarly transfer portions of Standard solution A, Standard solution B, and Standard solution C, and water to separate matching test tubes. Compare the Test solution, Standard solution A, Standard solution B, and Standard solution C, and water in diffused daylight, viewing vertically against a white background (see Visual Comparison under Spectrophotometry and Light Scattering 851 ). The Test solution is not more intensely colored than Standard solutions A, B, and C, or water. Identification, Infrared Absorption 197K Dry the substance to be examined at 105 for 2 hours. Bacterial endotoxins 85 If intended for use in the manufacturing of parenteral dosage forms, without a further appropriate procedure for the removal of bacterial endotoxins, not more that 0.5 I.U. of endotoxin per milligram. The level of bacterial endotoxins are such that the requirement under the relevant dosage form monograph(s) in which Anhydrous Citric Acid is used can be met. Where the label states that Anhydrous Citric Acid must be subjected to further processing during the preparation of injectable dosage forms, the level of bacterial endotoxins are such that the requirement under the relevant dosage form monograph(s) in which Anhydrous Citric Acid is used can be met. Sterility 71 Where the label states that Anhydrous Citric Acid is sterile, it meets the requirements for Sterility 71 under the relevant dosage form monograph(s) in which Anhydrous Citric Acid is used. Water, Method I 921 : not more than 1.0%. Residue on ignition 281 : not more than 0.1%, determined on 1.0 g. Readily carbonizable substances Transfer 1.0 g of powdered Anhydrous Citric Acid to a 22 175 mm test tube previously rinsed with 10 ml of sulfuric acid TS and allowed to drain for 10 minutes. Add 10 ml of sulfuric acid TS, agitate until solution is complete, and immerse in a water bath at 90 ± 1º for 60 ± 0.5 minutes, keeping the level of the acid below the level of the water during the entire period. Cool the tube in running water, and transfer the acid to a color comparison tube: the color of the acid is not darker than that of a similar volume of Matching Fluid K (see Color and Achromicity 631 ) in a matching tube, the tubes being observed vertically against a white background. Sulfate Standard sulfate solution A To 181 mg of dibasic potassium sulfate in a 100 ml volumetric flask, add a few ml of 30 percent alcohol, swirl to dissolve, dilute with 30 percent alcohol to volume, and mix. Immediately before use, transfer 10.0 ml of this solution to a 1000 ml http://www.usppf.com/pf/pub/index.html 4/6

volumetric flask, dilute with 30 percent alcohol to volume, and mix. This solution contains 10 µg of sulfate per ml. Standard sulfate solution B To 181 mg of dibasic potassium sulfate in a 100 ml volumetric flask, add a few ml of water, swirl to dissolve, dilute with water to volume, and mix. Immediately before use, transfer 10.0 ml of this solution to a 1000 ml volumetric flask, dilute with water to volume, and mix. This solution contains 10 µg of sulfate per ml. Citric acid solution Dissolve 2.0 g of Anhydrous Citric Acid in about 10 ml of water, dilute with water to 30 ml, and mix. Procedure To 4.5 ml of Standard sulfate solution A add 3 ml of a barium chloride solution (1 in 4), shake, and allow to stand for 1 minute. To 2.5 ml of the resulting suspension, add 15 ml of the Citric acid solution and 0.5 ml of 5 N acetic acid, and mix (test solution). Prepare the Standard solution in the same manner, except use 15 ml of Standard sulfate solution B instead of the Citric acid solution: any turbidity produced in the test solution after 5 minutes standing is not greater than that produced in the Standard solution (0.015%). Heavy metals 231 : 0.001%. Limit of oxalic acid Prepare a citric acid solution by dissolving 800 mg of Anhydrous Citric Acid in 4 ml of water. Add 3 ml of hydrochloric acid and 1 g of granular zinc, boil for 1 minute, and allow to stand for 2 minutes. Transfer the supernatant to a test tube containing 0.25 ml of a phenylhydrazine hydrochloride solution (1 in 100), and heat to boiling. Cool rapidly, transfer to a graduated cylinder, and add an equal volume of hydrochloric acid and 0.25 ml of a potassium ferricyanide solution (1 in 20). Shake, and allow to stand for 30 minutes (test solution). Concomitantly prepare a control solution in the same manner, except use 4 ml of an oxalic acid solution containing 0.10 mg per ml, equivalent to 0.0714 mg of anhydrous oxalic acid per ml, instead of the citric acid solution: any pink color produced in the test solution is not more intense than that produced in the control solution (0.036%). Limit of aluminum (where it is labeled as intended for use in dialysis) Standard aluminum solution To 352 mg of aluminum potassium sulfate in a 100 ml volumetric flask, add a few ml of water, swirl to dissolve, add 10 ml of diluted sulfuric acid, dilute with water to volume, and mix. Immediately before use, transfer 1.0 ml of this solution to a 100 ml volumetric flask, dilute with water to volume, and mix. ph 6.0 Acetate buffer Dissolve 50 g of ammonium acetate in 150 ml of water, adjust with glacial acetic acid to a ph of 6.0, dilute with water to 250 ml, and mix. Test solution Dissolve 20.0 g of Anhydrous Citric Acid in 100 ml of water, and add 10 ml of ph 6.0 Acetate buffer. Extract this solution with successive portions of 20, 20, and 10 ml of a 0.5% solution of 8 hydroxyquinoline in chloroform, combining the chloroform extracts in a 50 ml volumetric flask. Dilute the combined extracts with chloroform to volume, and mix. Standard solution Prepare a mixture of 2.0 ml of Standard aluminum solution, 10 ml of ph 6.0 Acetate buffer, and 98 ml of water. Extract this mixture as described for the Test solution, dilute the combined extracts with chloroform to volume, and mix. Blank solution Prepare a mixture of 10 ml of ph 6.0 Acetate buffer and 100 ml of water. Extract this mixture as described for the Test solution, dilute the combined extracts with chloroform to volume, and mix. Procedure Determine the fluorescence intensities of the Test solution and the Standard solution in a fluorometer set at an excitation wavelength of 392 nm and an emission wavelength of 518 nm, using the Blank solution to set the instrument to zero. The fluorescence of the Test solution does not exceed that of the Standard solution (0.2 µg per g). http://www.usppf.com/pf/pub/index.html 5/6

Organic volatile impurities, Method IV 467 : meets the requirements. Assay Place about 0.550 g of Anhydrous Citric Acid in a tared flask, and weigh accurately. Dissolve in 50 ml of water, add 0.5 ml of phenolphthalein TS, and titrate with 1 N sodium hydroxide VS. Each ml of 1 N sodium hydroxide is equivalent to 64.03 mg of C 6 H 8 O 7. USP28 Auxiliary Information Staff Liaison : Justin Lane, B.S., Scientific Associate Expert Committee : (EMC) Excipients: Monograph Content Pharmacopeial Forum : Volume No. 30(2) Page 677 Phone Number : 1 301 816 8323 http://www.usppf.com/pf/pub/index.html 6/6